{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:53:58Z","timestamp":1792101238515,"version":"4.4.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008982","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1648822"],"award-info":[{"award-number":["1648822"]}],"id":[{"id":"10.13039\/501100008982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY025687"],"award-info":[{"award-number":["R01EY025687"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["R01EY032342"],"award-info":[{"award-number":["R01EY032342"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY025585"],"award-info":[{"award-number":["P30EY025585"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["T32 EY024236"],"award-info":[{"award-number":["T32 EY024236"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["FG-1807-31882"],"award-info":[{"award-number":["FG-1807-31882"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000890","name":"National Multiple Sclerosis Society","doi-asserted-by":"publisher","award":["FG-2108-38411"],"award-info":[{"award-number":["FG-2108-38411"]}],"id":[{"id":"10.13039\/100000890","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Neurosci."],"abstract":"<jats:p>Neurodegeneration occurs early in the multiple sclerosis (MS) disease course and is an important driver of permanent disability. Current immunomodulatory therapies do not directly target neuronal health; thus, there is a critical need to develop neuroprotective strategies in MS. Outcome measures in clinical trials primarily evaluate disease activity and clinical disability scores rather than measures of neurodegeneration. The visual system provides a noninvasive correlate of brain atrophy and neuronal function through structural and functional exams. Furthermore, optic nerve axons and their respective neuronal cell bodies in the retina, in addition to their synaptic input to the thalamus, provide a distinct anatomy to investigate neurodegenerative processes. This review discusses the utility of the visual system as an early output measure of neurodegeneration in MS as well as an important platform to evaluate neuroprotective strategies in preclinical models.<\/jats:p>","DOI":"10.3389\/fnmol.2023.1125115","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T01:49:50Z","timestamp":1680054590000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Utility of the visual system to monitor neurodegeneration in multiple sclerosis"],"prefix":"10.3389","volume":"16","author":[{"given":"Gabrielle M.","family":"Mey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara M.","family":"DeSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1177\/1352458512439237","article-title":"Degeneration of retinal layers in multiple sclerosis subtypes quantified by optical coherence tomography","volume":"18","author":"Albrecht","year":"2012","journal-title":"Mult. Scler."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1002\/hbm.23946","article-title":"The retinal ganglion cell layer predicts normal-appearing white matter tract integrity in multiple sclerosis: a combined diffusion tensor imaging and optical coherence tomography approach","volume":"39","author":"Alves","year":"2018","journal-title":"Hum. Brain Mapp."},{"key":"ref3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12974-017-0936-0","article-title":"Inflammatory demyelination alters subcortical visual circuits","volume":"14","author":"Ara\u00fajo","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1177\/13524585211032801","article-title":"Impaired motion perception is associated with functional and structural visual pathway damage in multiple sclerosis and neuromyelitis optica spectrum disorders","volume":"28","author":"Ayadi","year":"2021","journal-title":"Mult. Scler. J."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.exer.2018.01.021","article-title":"Retinal conduction speed analysis reveals different origins of the P50 and N95 components of the (multifocal) pattern electroretinogram","volume":"169","author":"Bach","year":"2018","journal-title":"Exp. Eye Res."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3389\/fneur.2019.00455","article-title":"Vision and vision-related measures in progressive multiple sclerosis [original research]","volume":"10","author":"Backner","year":"2019","journal-title":"Front. Neurol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1212\/01.Wnl.0000154521.40686.63","article-title":"Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis","volume":"64","author":"Baier","year":"2005","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1177\/1352458517690822","article-title":"Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis","volume":"23","author":"Balcer","year":"2017","journal-title":"Mult. Scler."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jnnp-2014-308189","article-title":"Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis","volume":"86","author":"Balk","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.msard.2016.12.005","article-title":"Sensitivity of visual evoked potentials and spectral domain optical coherence tomography in early relapsing remitting multiple sclerosis","volume":"12","author":"Behbehani","year":"2017","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/s1474-4422(16)30377-5","article-title":"Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial","volume":"16","author":"Cadavid","year":"2017","journal-title":"Lancet Neurol."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.4049\/jimmunol.1501097","article-title":"Th cell diversity in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"195","author":"Carbajal","year":"2015","journal-title":"J. Immunol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"3943","DOI":"10.1093\/brain\/awac207","article-title":"Validating visual evoked potentials as a preclinical, quantitative biomarker for remyelination efficacy","volume":"145","author":"Cordano","year":"2022","journal-title":"Brain"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1016\/j.neuroscience.2009.09.069","article-title":"Functional recovery of callosal axons following demyelination: a critical window","volume":"164","author":"Crawford","year":"2009","journal-title":"Neuroscience"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s12974-019-1583-4","article-title":"Monitoring retinal changes with optical coherence tomography predicts neuronal loss in experimental autoimmune encephalomyelitis","volume":"16","author":"Cruz-Herranz","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"e149228","DOI":"10.1172\/jci.insight.149228","article-title":"Distinctive waves of innate immune response in the retina in experimental autoimmune encephalomyelitis","volume":"6","author":"Cruz-Herranz","year":"2021","journal-title":"JCI Insight"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/ana.25145","article-title":"Deep gray matter volume loss drives disability worsening in multiple sclerosis","volume":"83","author":"Eshaghi","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"eaax5936","DOI":"10.1126\/sciadv.aax5936","article-title":"Reduction of AMPA receptor activity on mature oligodendrocytes attenuates loss of myelinated axons in autoimmune neuroinflammation","volume":"6","author":"Evonuk","year":"2020","journal-title":"Sci. Adv."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/1352458517750009","article-title":"Optical coherence tomography angiography indicates associations of the retinal vascular network and disease activity in multiple sclerosis","volume":"25","author":"Feucht","year":"2019","journal-title":"Mult. Scler."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.ophtha.2005.10.040","article-title":"Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis","volume":"113","author":"Fisher","year":"2006","journal-title":"Ophthalmology"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3949\/ccjm.68.2.157","article-title":"Multiple sclerosis: the importance of early recognition and treatment","volume":"68","author":"Fox","year":"2001","journal-title":"Cleve. Clin. J. Med."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.ophtha.2005.10.017","article-title":"Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis","volume":"113","author":"Fraser","year":"2006","journal-title":"Ophthalmology"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ana.24030","article-title":"Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis","volume":"75","author":"Gabilondo","year":"2014","journal-title":"Ann. Neurol."},{"key":"ref24","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1212\/01.wnl.0000295995.46586.ae","article-title":"Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis","volume":"69","author":"Gordon-Lipkin","year":"2007","journal-title":"Neurology"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/ceo.12751","article-title":"Afferent visual pathways in multiple sclerosis: a review","volume":"45","author":"Graham","year":"2017","journal-title":"Clin. Experiment. Ophthalmol."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1167\/iovs.15-19047","article-title":"Progressive loss of retinal ganglion cells and axons in nonoptic neuritis eyes in multiple sclerosis: a longitudinal optical coherence tomography study","volume":"57","author":"Graham","year":"2016","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.2147\/opth.S6383","article-title":"Eye disorders in patients with multiple sclerosis: natural history and management","volume":"4","author":"Graves","year":"2010","journal-title":"Clin. Ophthalmol."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1016\/s0140-6736(17)32346-2","article-title":"Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial","volume":"390","author":"Green","year":"2017","journal-title":"Lancet"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/brain\/awq080","article-title":"Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration","volume":"133","author":"Green","year":"2010","journal-title":"Brain"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/s0140-6736(72)91155-5","article-title":"Delayed visual evoked response in optic neuritis","volume":"299","author":"Halliday","year":"1972","journal-title":"Lancet"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"27074","DOI":"10.1073\/pnas.1906358116","article-title":"Evoked potentials as a biomarker of remyelination","volume":"116","author":"Heidari","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1038\/eye.1997.231","article-title":"The pattern electroretinogram in anterior visual pathway dysfunction and its relationship to the pattern visual evoked potential: a personal clinical review of 743 eyes","volume":"11","author":"Holder","year":"1997","journal-title":"Eye"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/1742-2094-10-120","article-title":"Inflammatory demyelination induces glia alterations and ganglion cell loss in the retina of an experimental autoimmune encephalomyelitis model","volume":"10","author":"Horstmann","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":"Optical coherence tomography","volume":"254","author":"Huang","year":"1991","journal-title":"Science"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1212\/wnl.26.6_part_2.26","article-title":"Distribution of plaques in seventy autopsy cases of multiple sclerosis in the United States","volume":"26","author":"Ikuta","year":"1976","journal-title":"Neurology"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ajo.2019.12.021","article-title":"Visual function and disability are associated with increased retinal volumetric vessel density in patients with multiple sclerosis","volume":"213","author":"Jiang","year":"2020","journal-title":"Am. J. Ophthalmol."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s40478-019-0767-6","article-title":"Glial pathology and retinal neurotoxicity in the anterior visual pathway in experimental autoimmune encephalomyelitis","volume":"7","author":"Jin","year":"2019","journal-title":"Acta Neuropathol. Commun."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0022-510X(02)00428-8","article-title":"Neurophysiological evidence for long-term repair of MS lesions: implications for axon protection","volume":"206","author":"Jones","year":"2003","journal-title":"J. Neurol. Sci."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1191\/135248506ms1244oa","article-title":"Early abnormalities of evoked potentials and future disability in patients with multiple sclerosis","volume":"12","author":"Kallmann","year":"2006","journal-title":"Mult. Scler. J."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00401-009-0591-3","article-title":"The cuprizone animal model: new insights into an old story","volume":"118","author":"Kipp","year":"2009","journal-title":"Acta Neuropathol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"604049","DOI":"10.3389\/fneur.2020.604049","article-title":"Optical coherence tomography angiography (OCTA) in multiple sclerosis and Neuromyelitis Optica Spectrum disorder [review]","volume":"11","author":"Kleerekooper","year":"2020","journal-title":"Front. Neurol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s40263-018-0575-8","article-title":"Assessment of Opicinumab in acute optic neuritis using multifocal visual evoked potential","volume":"32","author":"Klistorner","year":"2018","journal-title":"CNS Drugs"},{"key":"ref43","doi-asserted-by":"publisher","first-page":"725187","DOI":"10.3389\/fnins.2021.725187","article-title":"Role of multifocal visually evoked potential as a biomarker of demyelination, spontaneous Remyelination, and myelin repair in multiple sclerosis [review]","volume":"15","author":"Klistorner","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"e1155","DOI":"10.1212\/nxi.0000000000001155","article-title":"Long-term effect of permanent demyelination on axonal survival in multiple sclerosis","volume":"9","author":"Klistorner","year":"2022","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1097\/wnp.0000000000000757","article-title":"Latency of multifocal visual evoked potential in multiple sclerosis: a visual pathway biomarker for clinical trials of Remyelinating therapies","volume":"38","author":"Klistorner","year":"2021","journal-title":"J. Clin. Neurophysiol."},{"key":"ref46","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1177\/1352458517729463","article-title":"Optical coherence tomography angiography retinal vascular network assessment in multiple sclerosis","volume":"24","author":"Lanzillo","year":"2018","journal-title":"Mult. Scler."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/1352458509359782","article-title":"Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients","volume":"16","author":"Laron","year":"2010","journal-title":"Mult. Scler."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1007\/s00415-020-09740-4","article-title":"Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis","volume":"267","author":"Magon","year":"2020","journal-title":"J. Neurol."},{"key":"ref49","doi-asserted-by":"publisher","first-page":"820155","DOI":"10.3389\/fnins.2022.820155","article-title":"Visual evoked potentials to monitor myelin Cuprizone-induced functional changes","volume":"16","author":"Marenna","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s40478-022-01391-y","article-title":"Visual imaging as a predictor of neurodegeneration in experimental autoimmune demyelination and multiple sclerosis","volume":"10","author":"Mey","year":"","journal-title":"Acta Neuropathol. Commun."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"e1583","DOI":"10.1002\/wsbm.1583","article-title":"Neurodegeneration in multiple sclerosis","volume":"15","author":"Mey","year":"","journal-title":"WIREs Mech Dis"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1177\/1352458519845116","article-title":"Alterations in the retinal vasculature occur in multiple sclerosis and exhibit novel correlations with disability and visual function measures","volume":"26","author":"Murphy","year":"2020","journal-title":"Mult. Scler."},{"key":"ref53","doi-asserted-by":"publisher","first-page":"e2240","DOI":"10.1212\/wnl.0000000000007450","article-title":"Damage of the lateral geniculate nucleus in MS: assessing the missing node of the visual pathway","volume":"92","author":"Papadopoulou","year":"2019","journal-title":"Neurology"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1002\/acn3.51473","article-title":"Optical coherence tomography in multiple sclerosis: a 3-year prospective multicenter study","volume":"8","author":"Paul","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.exer.2015.05.008","article-title":"Electrophysiological assessment of retinal ganglion cell function","volume":"141","author":"Porciatti","year":"2015","journal-title":"Exp. Eye Res."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1038\/nn.3168","article-title":"Animal models of multiple sclerosis: the good, the bad and the bottom line","volume":"15","author":"Ransohoff","year":"2012","journal-title":"Nat. Neurosci."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1212\/WNL.0b013e31827b1a1c","article-title":"Active MS is associated with accelerated retinal ganglion cell\/inner plexiform layer thinning","volume":"80","author":"Ratchford","year":"2013","journal-title":"Neurology"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.1038\/s41598-021-90036-6","article-title":"Differentiation between multiple sclerosis and neuromyelitis optica spectrum disorder using optical coherence tomography angiography","volume":"11","author":"Rogaczewska","year":"2021","journal-title":"Sci. Rep."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/ana.24487","article-title":"Optical coherence tomography reflects brain atrophy in multiple sclerosis: a four-year study","volume":"78","author":"Saidha","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1471-2377-14-31","article-title":"Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis","volume":"14","author":"Schinzel","year":"2014","journal-title":"BMC Neurol."},{"key":"ref61","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/bpa.12930","article-title":"Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis","volume":"31","author":"Sekyi","year":"2021","journal-title":"Brain Pathol."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1177\/1352458506070629","article-title":"Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis","volume":"12","author":"Shindler","year":"2006","journal-title":"Mult. Scler. J."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1002\/ana.25738","article-title":"Progressive multiple sclerosis is associated with faster and specific retinal layer atrophy","volume":"87","author":"Sotirchos","year":"2020","journal-title":"Ann. Neurol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1002\/ana.22005","article-title":"Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis","volume":"67","author":"Talman","year":"2010","journal-title":"Ann. Neurol."},{"key":"ref65","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1001\/archneur.65.6.727","article-title":"Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up","volume":"65","year":"2008","journal-title":"Arch. Neurol."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"103503","DOI":"10.1016\/j.msard.2022.103503","article-title":"Optical coherence tomography angiography (OCTA) in differential diagnosis of aquaporin-4 antibody seronegative NMOSD and multiple sclerosis","volume":"58","author":"Tiftikcioglu","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref68","first-page":"211","article-title":"Clinicopathological study of the visual pathways, eyes, and cerebral hemispheres in 32 cases of disseminated sclerosis","volume":"3","author":"Toussaint","year":"1983","journal-title":"J. Clin. Neuroophthalmol."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1056\/NEJM199801293380502","article-title":"Axonal transection in the lesions of multiple sclerosis","volume":"338","author":"Trapp","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1016\/j.ophtha.2011.11.032","article-title":"Ganglion cell loss in relation to visual disability in multiple sclerosis","volume":"119","author":"Walter","year":"2012","journal-title":"Ophthalmology"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40662-018-0104-3","article-title":"Emerging applications of optical coherence tomography angiography (OCTA) in neurological research","volume":"5","author":"Wang","year":"2018","journal-title":"Eye Vision"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.immuni.2019.12.004","article-title":"Targeted complement inhibition at synapses prevents microglial synaptic engulfment and synapse loss in demyelinating disease","volume":"52","author":"Werneburg","year":"2020","journal-title":"Immunity"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1212\/01.wnl.0000278387.15090.5a","article-title":"Relation of vision to global and regional brain MRI in multiple sclerosis","volume":"69","author":"Wu","year":"2007","journal-title":"Neurology"},{"key":"ref74","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1212\/nxi.0000000000000427","article-title":"Progressive inner nuclear layer dysfunction in non-optic neuritis eyes in MS","volume":"5","author":"You","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"6911","DOI":"10.1167\/iovs.11-7434","article-title":"Latency delay of visual evoked potential is a real measurement of demyelination in a rat model of optic neuritis","volume":"52","author":"You","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Frontiers in Molecular Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2023.1125115\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T01:49:55Z","timestamp":1680054595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnmol.2023.1125115\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":75,"alternative-id":["10.3389\/fnmol.2023.1125115"],"URL":"https:\/\/doi.org\/10.3389\/fnmol.2023.1125115","relation":{},"ISSN":["1662-5099"],"issn-type":[{"value":"1662-5099","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"article-number":"1125115"}}